Back
Harrow, Inc. Vs. NovaBay Pharmaceuticals, Inc. Industry Stock Comparison
Buy
69
HROW
Harrow, Inc.
Last Price:
$52.81
Seasonality Move:
-7.24%
Buy
70
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$6.67
Seasonality Move:
13.91%
Buy
69
Harrow, Inc. (HROW)
is a Buy
Is Harrow, Inc. a Buy, Sell or Hold?
-
The current Harrow, Inc. [HROW] share price is $49.00. The Score for HROW is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
HROW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $5.64. The Score for NBY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HROW Stock Price Chart
What is Harrow, Inc.'s stock price today?
-
The Harrow, Inc. share price today is $49.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HROW is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $5.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.
HROW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.14 | Buy |
| Relative Strength Index (14 RSI): | 59.22 | Buy |
| Chaikin Money Flow: | -484563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.93 - 49.85) | Buy |
| Bollinger Bands (100): | (36.93 - 46.11) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 71.51 | Buy |
| Chaikin Money Flow: | -26466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.22 - 4.68) | Buy |
| Bollinger Bands (100): | (0.58 - 3.08) | Buy |
HROW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.37 | Sell |
| 20-day SMA: | 47.78 | Buy |
| 50-day SMA: | 42.11 | Buy |
| 200-day SMA: | 35.21 | Buy |
| 8-day EMA: | 49.1 | Sell |
| 20-day EMA: | 47.19 | Buy |
| 50-day EMA: | 44.06 | Buy |
| 200-day EMA: | 37.9 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.2 | Buy |
| 20-day SMA: | 3.43 | Buy |
| 50-day SMA: | 2.03 | Buy |
| 200-day SMA: | 1.21 | Buy |
| 8-day EMA: | 5 | Buy |
| 20-day EMA: | 3.82 | Buy |
| 50-day EMA: | 2.49 | Buy |
| 200-day EMA: | 0.97 | Buy |
Harrow, Inc. Earnings Growth & HROW Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and an increase next year of $0.54 per share.
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Harrow, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||